News
Smart Portfolio
Markets
undefined
Research Tools
Research Tools
Top Stocks
Top Smart Score Stocks
New
Analysts' Top Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Daily Feeds
Daily Stock Ratings
Daily Insider Transactions
Screeners
Stock Screener
New
Stock Comparison
New
Smart Portfolio
Smart Portfolio
My Portfolio
Overview
My Holdings
My Portfolio Analysis
Crowd Insights
My Community
My Performance
My Public Profile
New
Top Experts
Top Experts
Find & Follow Experts
My Experts
Expert Center
Top Firms
Top Lists
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
New
News
News
Categories
Home
Market News
TipRanks Labs
Ideas & Insights
Stock Analysis
Trending Topics
Coronavirus Stocks
Dividend Stocks
Penny Stocks
FAANG Stocks
Calendars
Calendars
Calendars & Events
Earnings Calendars
Dividend Calendars
Stock Market Holidays
IPO Calendar
Plans & Pricing
News
Smart Portfolio
Markets
Notifications
All News
BIIB
Topic
Biogen’s 4Q Earnings Miss Street Estimates; Shares Fall 5.2%
Biogen’s shares dropped 5.2% on Feb. 3 as the biotech company’s fourth-quarter earnings fell short of analysts’ estimates....
Shrilekha Pethe
Feb 04, 2021
BIIB
Biogen Shares Gain 5.5% As FDA Extends Review Period For Alzheimer’s Drug
Biogen shares were up by 5.5% on Jan. 29 after the pharma company announced that the U.S. Food...
Shrilekha Pethe
Jan 31, 2021
BIIB
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021?
An unprecedented pandemic did not stop the US stock market from finishing 2020 on a high note. The...
Sirisha Bhogaraju
Jan 03, 2021
BIIB
GILD
Sage Therapeutics Gets $1.53B From Biogen in a Collaboration Deal
Sage Therapeutics received $1.525 billion from Biogen under the earlier announced collaboration and license agreement to jointly develop...
Amit Singh
Jan 03, 2021
BIIB
SAGE
Biogen Files For Japan Approval Of Potential Alzheimer Treatment; Street Says Hold
Biogen has filed a new drug application to Japan’s regulator for the approval of aducanumab, its investigational treatment...
Sharon Wrobel
Dec 10, 2020
BIIB
Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In
By a vote of one for, eight against, and two abstaining, the U.S. Food and Drug Administration’s (FDA)...
TipRanks Team
Nov 07, 2020
IBB
BIIB
Biogen Rockets 44% On “Substantial Evidence” For Alzheimer’s Drug Approval
Shares of Biogen exploded 44% after staff at the US Food and Drug Administration (FDA) concluded in a...
Sharon Wrobel
Nov 05, 2020
BIIB
Biogen’s Tecfidera Now Faces Cipla Generic Launch; Analyst Wary
Global pharma Cipla has announced that it has received final approval for its generic therapeutic equivalent version of...
Harriet Lefton
Sep 29, 2020
BIIB
AbbVie vs Biogen: Which Drugmaker Scores A ‘Strong Buy’ Street Consensus?
The COVID-19 pandemic has led to a wake-up call for governments, as they realize the significant investment required...
Sirisha Bhogaraju
Aug 26, 2020
ABBV
BIIB
Biogen Spikes 10% On FDA Fast Review For Potential Alzheimer Treatment
Shares in Biogen leaped 10% on Friday after the company said that the U.S. Food and Drug Administration...
Sharon Wrobel
Aug 09, 2020
BIIB
Biogen Rises 4% As Morgan Stanley Upgrades Stock To Buy
Shares in Biogen (BIIB) rose over 4% in early-market trading on Monday, after Morgan Stanley lifted the stock’s rating...
Amit Singh
Jul 27, 2020
BIIB
Biogen, Eisai Start New Phase 3 Trial For Pre-clinical Alzheimer’s Disease
Biogen (BIIB), in collaboration with Eisai, and the Alzheimer’s Clinical Trials Consortium, has initiated a new global Phase...
Harriet Lefton
Jul 14, 2020
BIIB
Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan
Not all biotechs are highflyers in 2020. Despite some pharma companies’ elevated coronavirus driven valuations, some have had...
Marty Shtrubel
Jul 11, 2020
BIIB
Biogen Files FDA Application For Potential Alzheimer Treatment
Biogen Inc. (BIIB) announced that it has finally submitted the Biologics License Application (BLA) seeking approval by the...
Sharon Wrobel
Jul 09, 2020
BIIB
You need to enable JavaScript to run this app.